DOMPE
Daniela Iaconis is a Senior Biology Scientist and Preclinical Pharmacology Manager at Dompé since July 2020, overseeing preclinical pharmacology activities for drug discovery and repositioning. Prior to this role, Daniela worked as a researcher at Stazione Zoologica Anton Dohrn, contributing to the ADViSE project focused on transcriptomics in cancer cells. Daniela has substantial research experience from Fondazione Telethon, where activities included human genetics and renal cystic disease. Additionally, Daniela offered lectures for the Society of Italian Nephrology and held a research fellowship at INSERM. Educational qualifications include a PhD from the European School of Molecular Medicine, a Master's degree in Medical Biotechnology, and a Bachelor's degree in Health Biotechnologies from the University of Naples "Federico II." Furthermore, Daniela completed a Master of Project Management at 24ORE Business School.
DOMPE
2 followers
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personalhygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory.Founded in 1940, Dompe is headquartered in Milan, Italy.